Trending...
- New Book Warring From the Standpoint of the Throne Room Calls Believers to Pray From Victory
- RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
- The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
Single ~ CS Genetics, a leading company in next-generation single-cell genomics, has announced the launch of their latest product, the SimpleCell™ 3' Gene Expression kits. This is the company's first commercial offering and is designed to make single-cell transcriptomics more accessible and scalable.
The SimpleCell™ platform utilizes Kinetic Confinement, a revolutionary molecular process, to provide an instrument-free and scalable solution for single-cell genomics. This technology has been in development for several years and is now being released commercially.
Luke Edelman, Founder and Chief Technology Officer at CS Genetics, expressed his excitement about the launch of SimpleCell™. He stated, "After several years of development, we are so excited to be releasing our first SimpleCell™ products commercially. Single cell is a very important and impactful modality for biological measurement, and we feel strongly that a diverse ecosystem of technology platforms – now including Kinetic Confinement and SimpleCell™ – is good for the field and for the cadence of discovery."
More on The PennZone
The SimpleCell™ 3' Gene Expression kits have several key features that make them stand out in the market. These include a single-day cells-to-sequencer workflow using standard lab equipment and pipetting, cost-effectiveness at under $500 per sample regardless of experiment scale or purchase volume, and compatibility with various sample types such as blood/PBMCs, cell lines, disaggregated solid tissues, and more.
CS Genetics will be showcasing details about Kinetic Confinement technology and the SimpleCell™ product line at the 2024 Annual Meeting of the American Society for Human Genetics in Denver. Attendees can visit CS Genetics at booth 402 or join the SimpleCell™ CoLab talk on Wednesday, November 6th at 4:00 PM in Theater 3 to learn more about the future of single-cell genomics.
Early customers of SimpleCell™ have already expressed their satisfaction with the product. Charlly Kao, Principal Scientist at the Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia, shared, "We've been eagerly waiting for something like SimpleCell™ that can perform single-cell transcriptome profiling in a flexible, instrument-free, and simple-to-use workflow at a more attractive price point."
More on The PennZone
Hákon Hákonarson, Director of the Center for Applied Genomics at the Children's Hospital of Philadelphia and Professor of Pediatrics at the Perelman School of Medicine, also commented on the potential impact of SimpleCell™. He said, "Kinetic Confinement and the SimpleCell™ platform are timely new additions to the single cell universe. As a translational research facility with access to a very large number of clinical specimens, we are particularly excited about the opportunities presented by the platform to enable significantly larger-scale single cell studies than has been realistically possible with other tools."
Yuriy Alekseyev, director of the Single Cell and NGS core laboratory at Boston University Chobanian & Avedisian School of Medicine, also praised SimpleCell™ for its affordability and ease-of-use. He stated, "SimpleCell™ checks these boxes well. It's simple to set up, cost-effective, and a welcome addition for users who've been looking for a platform that doesn't require a huge learning curve or large costs for each experiment."
The SimpleCell™ 3' Gene Expression kits are available in 8-sample and 16-sample sizes and can now be ordered for shipment across the U.S., U.K., Europe, and select global regions through CS Genetics' website. To learn more about this innovative product or to place an order, visit www.csgenetics.com.
The SimpleCell™ platform utilizes Kinetic Confinement, a revolutionary molecular process, to provide an instrument-free and scalable solution for single-cell genomics. This technology has been in development for several years and is now being released commercially.
Luke Edelman, Founder and Chief Technology Officer at CS Genetics, expressed his excitement about the launch of SimpleCell™. He stated, "After several years of development, we are so excited to be releasing our first SimpleCell™ products commercially. Single cell is a very important and impactful modality for biological measurement, and we feel strongly that a diverse ecosystem of technology platforms – now including Kinetic Confinement and SimpleCell™ – is good for the field and for the cadence of discovery."
More on The PennZone
- Innovative Environmental Technologies Unveils New Website Featuring Free AI Tools for the Environmental Industry
- CCHR Warns: Psychiatric Diagnoses Without Biological Proof Now Used to Justify Euthanasia
- Going Solo Life publishes new travel guide for 2026
- JL Tox Consulting Responds to New ISO 10993-1:2025 Biocompatibility Standard Release
- Impact Filtration Appoints Alejandro Sturniolo as Head of Sustainability to Engineer High-Performance, Water-Positive Infrastructure
The SimpleCell™ 3' Gene Expression kits have several key features that make them stand out in the market. These include a single-day cells-to-sequencer workflow using standard lab equipment and pipetting, cost-effectiveness at under $500 per sample regardless of experiment scale or purchase volume, and compatibility with various sample types such as blood/PBMCs, cell lines, disaggregated solid tissues, and more.
CS Genetics will be showcasing details about Kinetic Confinement technology and the SimpleCell™ product line at the 2024 Annual Meeting of the American Society for Human Genetics in Denver. Attendees can visit CS Genetics at booth 402 or join the SimpleCell™ CoLab talk on Wednesday, November 6th at 4:00 PM in Theater 3 to learn more about the future of single-cell genomics.
Early customers of SimpleCell™ have already expressed their satisfaction with the product. Charlly Kao, Principal Scientist at the Center for Applied Genomics (CAG) at the Children's Hospital of Philadelphia, shared, "We've been eagerly waiting for something like SimpleCell™ that can perform single-cell transcriptome profiling in a flexible, instrument-free, and simple-to-use workflow at a more attractive price point."
More on The PennZone
- 106 Years Strong: The Liberty Group Celebrates a Century-Plus of Service and Unveils a Unified Family of Companies
- Airport Transportation Reaches All Five Continents Through Global Transportation Partner Network
- Acquisition of Israeli Defense Manufacturing Platform to Accelerate AI-Driven Autonomous Systems: VisionWave Holdings, Inc.: (N A S D A Q: VWAV)
- HRC Fertility to Celebrate Grand Opening of New Beverly Hills Location During National Infertility Awareness Week
- AktieGo Publishes Editorial Feature Examining Decentralized Power Infrastructure and Hydrogen Energy Deployment
Hákon Hákonarson, Director of the Center for Applied Genomics at the Children's Hospital of Philadelphia and Professor of Pediatrics at the Perelman School of Medicine, also commented on the potential impact of SimpleCell™. He said, "Kinetic Confinement and the SimpleCell™ platform are timely new additions to the single cell universe. As a translational research facility with access to a very large number of clinical specimens, we are particularly excited about the opportunities presented by the platform to enable significantly larger-scale single cell studies than has been realistically possible with other tools."
Yuriy Alekseyev, director of the Single Cell and NGS core laboratory at Boston University Chobanian & Avedisian School of Medicine, also praised SimpleCell™ for its affordability and ease-of-use. He stated, "SimpleCell™ checks these boxes well. It's simple to set up, cost-effective, and a welcome addition for users who've been looking for a platform that doesn't require a huge learning curve or large costs for each experiment."
The SimpleCell™ 3' Gene Expression kits are available in 8-sample and 16-sample sizes and can now be ordered for shipment across the U.S., U.K., Europe, and select global regions through CS Genetics' website. To learn more about this innovative product or to place an order, visit www.csgenetics.com.
Filed Under: Business
0 Comments
Latest on The PennZone
- Peccioli Becomes New Orleans: In July 2026, the magic of jazz comes to Tuscany
- $6 Million Funding Secured as Retail Expansion, Operational Streamlining, and Asset-Light Strategy Position the Company for Accelerated Growth $SOWG
- The "Unsexy" Business Quietly Creating 130+ New Entrepreneurs Across America — From Alaska to Puerto Rico
- Veteran Launches GTG Energy: Nicotine-Free Pouch as Americans Rethink Addiction, Focus, and What Fuels Performance
- RecallSentry™ App Launch — Your Home Safety Hub — Free on iOS & Android
- Award-Winning Director Crystal J. Huang's Under-$50K Film "The Ritual House" Wins Best Horror Feature at Golden State Film Festival
- Grads aren't getting hired — here's what we're doing about it
- L-Tron Returns from a Successful PACK EXPO East Conference
- K2 Integrity Enhances Technology Capabilities Through Acquisition of Leviathan Security Group
- #WeAreGreekWarriors Comes to Detroit in Celebration of Women's History Month
- JKS Financial Marks Five-Year Partnership with University of Pittsburgh Basketball, United Way
- Energywise Solutions and Pickleball Pros Partner to Bring More Energy and Visibility to Pickleball Clubs
- Buildout Launches CRM, Completing the Industry's First AI-Powered End-to-End Deal Engine for CRE
- The Franchise King® Releases Free Guide for Nervous Buyers
- Kanguro Insurance Taps Paylode to Launch Best-in-Class Pet and Renters Insurance Rewards Experience
- CCHR: CIA Mind-Control Files Raise Urgent Questions as Millions Take Psychotropic Drugs
- NRx Pharmaceuticals Launches Breakthrough One-Day Treatment Clinic in Florida as FDA Pathway and Clinical Data Strengthen Growth Outlook; $NRXP
- Revenue Optics Launches Talent Infrastructure Platform for SaaS Revenue Hiring and Appoints Sabz Kaur to Lead Growth
- Building a Multi-Domain Autonomous Systems Platform at the Intersection of AI, Defense and Infrastructure: VisionWave Holdings (N A S D A Q: VWAV)
- Bent Danholm Named "Top Luxury Real Estate Leader" in Modern Luxury Miami